Exploring Hypofractionated Radiotherapy Efficacy in Prostate Cancer: In Vitro Insights
Radiation · 20.12.2024 · 4 (4) · 378-396
DOI: 10.3390/radiation4040029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Radiation, online erschienen am 20.12.2024. Verfasst von Peter du Plessis und 3 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Southern African Institute for Nuclear Technology & Sciences (SAINTS).
Abstract (Originalsprache)
The rising incidence of prostate cancer necessitates innovative treatment approaches, particularly as diseases such as the COVID-19 pandemic can disrupt traditional cancer care. This study aims to evaluate the impact of hypofractionated versus conventionally fractionated radiotherapy on prostate cancer cell lines in vitro. Prostate cancer cell lines (PC-3 and DU-145) were exposed to varying doses of radiation alongside non-cancerous BPH-1 cells. We assessed radiation effects on cell proliferation, viability, colony formation, DNA repair, migration, invasion, and cytotoxicity. The results demonstrated that the prostate cell lines exhibited varying responses, with hypofractionation favourably impacting aggressive PC-3 cells while preserving non-cancerous cells. In contrast, conventional fractionation led to increased invasion and cytotoxicity in both prostate cancerous cell lines. These findings advocate for personalised radiation therapy approaches that enhance treatment efficacy by considering the distinct behaviours of differing prostate cancer subtypes.
Förderung
- Southern African Institute for Nuclear Technology & Sciences (SAINTS)
Zitieren
APA
Plessis, P. D., Nkosi, P. B., Nair, S., & Akudugu, J. (2024). Exploring Hypofractionated Radiotherapy Efficacy in Prostate Cancer: In Vitro Insights. Radiation, 4(4), 378-396. https://doi.org/10.3390/radiation4040029
Vancouver
Plessis PD, Nkosi PB, Nair S, Akudugu J. Exploring Hypofractionated Radiotherapy Efficacy in Prostate Cancer: In Vitro Insights. Radiation. 2024;4(4):378-396. doi:10.3390/radiation4040029
BibTeX
@article{Plessis2024,
author = {Plessis, Peter du and Nkosi, Pauline Busisiwe and Nair, Shankari and Akudugu, John},
title = {Exploring Hypofractionated Radiotherapy Efficacy in Prostate Cancer: In Vitro Insights},
journal = {Radiation},
year = {2024},
volume = {4},
number = {4},
pages = {378--396},
doi = {10.3390/radiation4040029}
}
EUVIMED